Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Small Cap Biotech Companies With Future Potential
Seeking Alpha
Friday, June 24, 2011 - 10:25am
tags:
Antares, Adventrx, BioSante
After the breakup: the end of a partnership with big pharma brings both opportunity and challenge for biotech firms
Chemical and Engineering News
Friday, June 24, 2011 - 10:17am
tags:
Exelixis, Bristol-Myers Squibb
Acadia Pharmaceuticals: Investing With No Safety Net
TheStreet.com
Friday, June 24, 2011 - 10:14am
tags:
Acadia
Aegerion says stock offering prices at $15.50
Yahoo/AP
Friday, June 24, 2011 - 10:13am
tags:
Aegerion, stock offering, lomitapide
Roche Intends to Jointly Develop Biomarkers in Oncology Drugs With Evotec
Bloomberg
Friday, June 24, 2011 - 9:37am
tags:
oncology, Roche, biomarkers, Evotec
Analyst expects positive cancer drug trial results from Oncothyreon later this year
Yahoo/AP
Friday, June 24, 2011 - 9:24am
tags:
Oncothyreon, Stimuvax, lung cancer
IntelliPharmaCeutics Investors Should Welcome Litigation Settlement
Seeking Alpha
Friday, June 24, 2011 - 9:22am
tags:
Intellipharmaceutics, investors, Pfizer, Effexor XR
Biogen to take $50M hit from lymphoma drug dispute
Bizjournals.com
Friday, June 24, 2011 - 9:21am
tags:
lymphoma, Biogen Idec, Rituxan
Pfizer, Pain Therapeutics Drug Rejected by FDA
TheStreet.com
Friday, June 24, 2011 - 9:17am
tags:
Pfizer, Pain Therapeutics, FDA, Remoxy
High Yield Big Pharmaceutical Stocks
Seeking Alpha
Friday, June 24, 2011 - 9:16am
tags:
GSK, JNJ, Merck, Pfizer
Supreme Court Sides With Generic Drug Makers
WSJ Online
Friday, June 24, 2011 - 9:13am
tags:
generics, Supreme Court
AstraZeneca: Rich Dividend Yield, But Pipeline, Earnings Challenges on the Horizon
Seeking Alpha
Friday, June 24, 2011 - 9:11am
tags:
AstraZeneca, pipelines, earnings, dividends
Avanir Pharmaceuticals: Seldom a Dull Moment
Seeking Alpha
Thursday, June 23, 2011 - 6:53pm
tags:
Avanir
Glaxo to pay 37 states $41M over faulty drugs
Yahoo/AP
Thursday, June 23, 2011 - 6:49pm
tags:
GSK, settlements
Blood-thinner study shakes Big Pharma stocks
Marketwatch
Thursday, June 23, 2011 - 6:48pm
tags:
blood thinners, Pfizer, JNJ, Sanofi, Bristol-Myers Squibb
Diamyd ends late-stage study of diabetes-prevention drug
Fierce Biotech
Thursday, June 23, 2011 - 11:10am
tags:
Diamyd Medical, diabetes
Lilly CEO: Ease immigration laws to boost innovation
Fierce Biotech
Thursday, June 23, 2011 - 11:09am
tags:
Eli Lilly, innovation, Pharma CEOs, John Lechleiter
4-Star Stocks Poised to Pop: ViroPharma
Motley Fool
Thursday, June 23, 2011 - 11:07am
tags:
ViroPharma
Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Bloomberg
Thursday, June 23, 2011 - 9:12am
tags:
Avandia, diabetes, Bristol-Myers Squibb, Actos, Takeda, AstraZeneca, Dapagliflozin
Biotech firms want drug approval hastened
Boston Globe, MA
Thursday, June 23, 2011 - 9:06am
tags:
drug approvals, biotech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.